Reger et al. [116] conducted research to see if delivering insulin into the brain of people with Alzheimer’s disease or amnestic moderate cognitive impairment (MCI) would improve memory without increasing plasma insulin levels. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.